or Try an Advanced Search...

    Takeda Pharmaceutical Company Stocks List

    Symbol Grade Name % Change
    AMGN B Amgen Inc. -0.22
    STTK B Shattuck Labs, Inc. 0.00
    XOMA C XOMA Corporation -0.68
    ITCI C Intra-Cellular Therapies Inc. -1.25
    ALNY D Alnylam Pharmaceuticals, Inc. -1.08
    LXRX D Lexicon Pharmaceuticals, Inc. 0.62
    CRDF D Cardiff Oncology, Inc. 4.24
    OVID D Ovid Therapeutics Inc. -0.33
    RXRX F Recursion Pharmaceuticals, Inc. 1.44
    GOSS F Gossamer Bio, Inc. -2.65
    View As Page of Charts
    Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic
    Related Stock Lists: Biopharmaceutical Biotechnology Life Sciences Medicine Prostate Cancer Solid Tumors Advanced Solid Tumors Cancer Clinical Development Clinical Trial Diabetes Disorders Drug Discovery Drugs Human Diseases Immunology Inflammation Lymphoma Monoclonal Antibodies Neuroscience

    Related ETFs - A few ETFs which own one or more of the above listed Takeda Pharmaceutical Company stocks.

    Symbol Grade Name Weight
    BBH C Market Vectors Biotech ETF 18.08
    IBBQ C Invesco Nasdaq Biotechnology ETF 12.27
    IBB D iShares Nasdaq Biotechnology Index Fund 11.86
    FBT D First Trust Amex Biotech Index Fund 10.19
    BIS D ProShares UltraShort Nasdaq Biotechnology 9.95
    View all Takeda Pharmaceutical Company ETFs...
    Compare ETFs
    Compare BBH to FBT Compare IBBQ to BIS Compare IBBQ to IBB

        Takeda Pharmaceutical Company Stocks Recent News

        Date Stock Title
        May 26 AMGN Amgen's Catching Up to Novo Nordisk and Eli Lilly. Should You Buy It?
        May 26 AMGN The Biggest Publicly Traded Biotech Company
        May 25 AMGN Viking, CRISPR, Intellia among potential M&A targets: Wells Fargo
        May 25 AMGN It's Unlikely That Amgen Inc.'s (NASDAQ:AMGN) CEO Will See A Huge Pay Rise This Year
        May 24 RXRX Recursion Appoints Robert Hershberg M.D., Ph.D, as New Chair of the Board
        May 24 AMGN The Zacks Analyst Blog Highlights Apple, Mastercard, Amgen, Utah Medical Products and Bridger Aerospace
        May 24 RXRX 2 Stocks That Could 10x by 2035
        May 23 AMGN Top Stock Reports for Apple, Mastercard & Amgen
        May 23 RXRX Here is What to Know Beyond Why Recursion Pharmaceuticals, Inc. (RXRX) is a Trending Stock
        May 23 RXRX Jim Cramer Offers His Take On Corning, Calls This Healthcare Stock A 'Terrific Spec'
        May 23 ITCI Intra-Cellular Therapies Highlights Data Presentations at the American Society of Clinical Psychopharmacology Annual Meeting
        May 22 AMGN Roche’s Tina-quant Lp(a) test receives FDA breakthrough device designation
        May 22 CRDF Cardiff Oncology's Onvansertib: A Speculative Buy With Promising Data
        May 21 AMGN Amgen Stock: Poised To Break Out (Technical Analysis)
        May 21 STTK After Plunging -19.89% in 4 Weeks, Here's Why the Trend Might Reverse for Shattuck Labs (STTK)
        May 21 AMGN Amgen, Inc. (AMGN) ATS and the Approval of IMDELLTRA Conference - (Transcript)
        May 20 AMGN Amgen/AstraZeneca Say Asthma Drug Shows Activity In Another Lung Disease Across Broad Patient Population
        May 20 AMGN 7 Biotech Stocks That Could Breathe New Life Into Your Portfolio
        May 20 AMGN AstraZeneca, Amgen release mid-stage data on Tezspire for COPD
        Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic
        Related Stock Lists: Biopharmaceutical Biotechnology Life Sciences Medicine Prostate Cancer Solid Tumors Advanced Solid Tumors Cancer Clinical Development Clinical Trial Diabetes Disorders Drug Discovery Drugs Human Diseases Immunology Inflammation Lymphoma Monoclonal Antibodies Neuroscience
        Takeda Pharmaceutical Company

        The Takeda Pharmaceutical Company Limited (武田薬品工業株式会社, Takeda Yakuhin Kōgyō kabushiki gaisha) [takeꜜda jakɯçiŋ koꜜːɡʲoː] is a Japanese multinational pharmaceutical and biopharmaceutical company. It is the largest pharmaceutical company in Asia and one of the top 20 largest pharmaceutical companies in the world by revenue (top 10 following merger with Shire). The company has over 49,578 employees worldwide and achieved US $19.299 billion in revenue during the 2018 fiscal year. The company is focused on metabolic disorders, gastroenterology, neurology, inflammation, as well as oncology through its independent subsidiary, Takeda Oncology. Its headquarters is located in Chuo-ku, Osaka, and it has an office in Nihonbashi, Chuo, Tokyo.
        In January 2012, Fortune Magazine ranked the Takeda Oncology Company as one of the 100 best companies to work for in the United States.

        More about Takeda Pharmaceutical Company
        Browse All Tags